Preview

Nephrology (Saint-Petersburg)

Advanced search

DYNAMICS OF THE INDICES OF CHRONIC HEART FAILURE IN CHRONIC KIDNEY DISEASE PATIENTS WITH RENAL REPLACEMENT THERAPY

https://doi.org/10.24884/1561-6274-2006-10-1-35-39

Abstract

THE AIM of the work was to study the dynamics of clinical manifestations of chronic heart failure (CHF) and structural-functional alterations in the myocardium in patients with chronic kidney disease (CKD) at the predialysis stage and during the first year of program hemodialysis. PATIENTS AND METHODS. The work included 65 patients (29 men and 36 women, mean age 43.1±11.1 years) with the IV-V stage CKD (NKF, 2002): the estimation of the findings of clinical and echocardiographic investigations was made at the predialysis stage and during the first year of hemodialysis according to the national recommendations on diagnostics and treatment of CHF (2003). RESULTS. At the predialysis stage of CKD CHF was diagnosed in 56 patients (86.2%): I stage in 19 (33.9%), IIA – in 28 (50.0%), IIB – in 9 (16.1%) patients. During the first year of program hemodialysis the diagnosis of CHF was abolished in 14 patients (25%), in 42 patients (75%) it was confirmed: I stage – in 22 (52.4%), IIA stage – in 17 (40.5%), IIB stage – in 3 (7.1%) patients. In all cases CHF became apparent as a diastolic dysfunction of the myocardium, in some cases – in combination with systolic (16.1% and 7.1% at the predialysis stage and in the first year of hemodialysis respectively). During the first year of renal-substitutive therapy the incidence of CHF was 21.6% less and made up 64.6% of cases. In the structure of CHF the Ist stage was prevailing, the shares of the IIA and IIB became 1.2 and 2.3 times less. CONCLUSION. The reversibility of main manifestations of CHF in patients with renal cardiopathy stresses the necessity of timely detection and adequate correction of risk factors of cardiac complications. It is expedient to use the criteria of severity of renal cardiopathy in the assessment of adequacy of treatment of CKD for solving the question of timely administration of program hemodialysis.

About the Authors

V. V. Belov
Челябинская государственная медицинская академия
Russian Federation


V. V. Ilyicheva
Челябинская государственная медицинская академия
Russian Federation


References

1. Смирнов АВ, Добронравов ВА, Румянцева АШ и соавт. Факторы риска ИБС у больных, получающих лечение гемодиализом. Нефрология 2003; 7: 30-35

2. Nitta K, Akiba T, Ucbida K et al. Left ventricular hypertrophy is associated with arterial stiffnes and vascular calcification in hemodialysis patients. Hypertens Res 2004; 1: 47-52

3. Беленков ЮН, Мареев ВЮ. Сердечно-сосудистый континуум. Сердечная недостаточность 2002; 3: 7-13

4. Багрий АЭ. Сердечно-сосудистые нарушения при хронической почечной недостаточности. Тер арх 1998; 11: 83-86

5. LeveyAS, Eknoyan G. Cardiovascular disease in chronic renal disease. Nephrol Dial Transplant 1999; 14: 828-833

6. Национальные рекомендации по диагностике и лечению ХСН (утвержденные съездом кардиологов РФ в октябре 2003 г.). Сердечная недостаточность 2003; 6: 276-297

7. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis 2002; 39[Suppl.1]: S17-S31

8. Scbiller NB, Sbab PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 358-367

9. Devereux RB, Alonso DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458

10. Abergel Е, Tase М, Bohlader J. Which definition echocardiographic left ventricular hypertrophy? Am J Cardiol 1995; 75: 489-503

11. Canau A, Devereux RB, Roman MJ et al. Patterns of left ventricular hypertrophy and geometric remodelling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550-1558

12. Профилактика, диагностика и лечение артериальной гипертензии. Российские рекомендации (второй пересмотр). Разработаны Комитетом экспертов Всероссийского научного общества кардиологов. Секция артериальной гипертонии ВНОК. Москва: MEDIA MEDICA; 2005

13. Шутов АМ, Мардер НЯ, Хамидулина ГА и др. Хроническая сердечная недостаточность у больных с хронической болезнью почек. Нефрология и диализ 2005; 2: 140-144

14. Partbenakis FI, Kanopakis EM, Kocbidiakis GR et al. Left ventricular diastolic filling pattern predicts cardiopulmonary determination of functional capacity in patients with congestive heart failure. Am Heart J 2000; 140: 338-344

15. Шутов АМ, Кондратьева НИ, Ивашкина ТН и др. Диастолическая дисфункция и клинические проявления сердечной недостаточности у больных с додиализной хронической почечной недостаточностью. Нефрология 2001; 4:30-34

16. Coben-Solar A. Lefft ventricular diastolic dysfunction: pathophysiology, diagnosis and treatment. Nephrol Dial Transplant 1998; 13 [Suppl. 4]: 3-5

17. Amann K, Tyralla K. Cardiovascular changes in chronic renal failure-pathogenesis and therapy. Clin Nephrol 2002; 7: 6272

18. Amann K, Ritz E. Cardiac disease in chronic uremia: pathophysiology. Adv Ren Replace Ther 1997; 7: 212-224


Review

For citations:


Belov V.V., Ilyicheva V.V. DYNAMICS OF THE INDICES OF CHRONIC HEART FAILURE IN CHRONIC KIDNEY DISEASE PATIENTS WITH RENAL REPLACEMENT THERAPY. Nephrology (Saint-Petersburg). 2006;10(1):35-39. (In Russ.) https://doi.org/10.24884/1561-6274-2006-10-1-35-39

Views: 459


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)